Wuhan Eyegood Ophthalmic Hospital
Latest round
- Series B
Last raised
- Mar 2018
Total raised
- $40M
Investors
- 4
About Wuhan Eyegood Ophthalmic Hospital
Based in Wuhan, China and established in 2003, Wuhan Eyegood Ophthalmic Hospital is an eye hospital which offers eye disease therapy, refractive surgery, ocular plastic surgery, optometry, etc.
Who invested in Wuhan Eyegood Ophthalmic Hospital
4 investors across 3 rounds
See all investors in Wuhan Eyegood Ophthalmic Hospital
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Wuhan Eyegood Ophthalmic Hospital
Who invested in Wuhan Eyegood Ophthalmic Hospital?
Wuhan Eyegood Ophthalmic Hospital has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wuhan Eyegood Ophthalmic Hospital raised?
Wuhan Eyegood Ophthalmic Hospital has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Wuhan Eyegood Ophthalmic Hospital last raise money?
Wuhan Eyegood Ophthalmic Hospital's most recent round on record is a Series B, in Mar 2018.
What does Wuhan Eyegood Ophthalmic Hospital do?
Based in Wuhan, China and established in 2003, Wuhan Eyegood Ophthalmic Hospital is an eye hospital which offers eye disease therapy, refractive surgery, ocular plastic surgery, optometry, etc.
Where is Wuhan Eyegood Ophthalmic Hospital headquartered?
Wuhan Eyegood Ophthalmic Hospital is headquartered in Wuhan, China.
Which VCs invest in companies like Wuhan Eyegood Ophthalmic Hospital?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Wuhan Eyegood Ophthalmic Hospital's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Wuhan Eyegood Ophthalmic Hospital? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.